ACHC Earnings & Financial Statements
Acadia Healthcare Company, Inc.
$31.67
+$1.44(+4.76%)
56
Overall
60
Value
63
Tech
47
Quality
Market Cap
$2.95B
Volume
1.81M
52W Range
$11.43 - $35.83
Target Price
$33.60
ACHC earnings and financial statements: Acadia Healthcare Company, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ACHC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B |
| Cost of revenue | $118.05M | $112.71M | $105.99M | $100.20M | $90.70M |
| Operating income | $413.58M | $475.52M | $576.92M | $422.45M | $365.90M |
| EBITDA | -$732.95M | $611.93M | $324.78M | $564.93M | $459.47M |
| Net income | -$1.10B | $255.61M | -$21.67M | $273.14M | $190.63M |
| EPS (diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B |
| Shareholders’ equity | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B |
| Cash and equivalents | $133.24M | $76.31M | $100.07M | $97.65M | $133.81M |
| Long-term debt | $2.59B | $1.98B | $1.44B | $1.48B | $1.60B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $131.90M | $129.69M | $462.34M | $380.57M | $374.48M |
| Capital expenditure | -$547.96M | -$679.95M | -$424.13M | -$296.15M | -$244.81M |
| Free cash flow | -$439.91M | -$560.69M | $38.21M | $84.42M | $129.67M |
| Dividends paid | - | - | - | - | $1.59M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACHC | $31.67 | +4.8% | 1.81M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Acadia Healthcare Company, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW